Replay_Logo_Black_CMYK.png
Replay and its engineered NK cell therapy company Syena announce exclusive licensing agreement with National Institutes of Health for TCRs targeting cancer neoantigens
December 18, 2023 07:00 ET | Replay Bio
Replay and its engineered NK cell therapy company Syena announce exclusive licensing agreement with National Institutes of Health for TCRs targeting cancer neoantigens Replay and its...
First-Wave-Logo-FINAL-RGB[1].jpg
First Wave BioPharma Announces Entry into Term Sheet for Business Combination with ImmunogenX Establishing a Leading Late-Stage GI-Focused Biopharmaceutical Company
December 18, 2023 06:00 ET | First Wave BioPharma, Inc.
Phase 3-ready latiglutenase, a targeted oral biotherapeutic for celiac disease, will expand First Wave BioPharma’s late-stage gastrointestinal (GI) disease clinical pipeline A concurrent...
Transparency Market Research
Actuators and Valves Market Size to Exceed USD 615.6 million By 2031, with a Robust CAGR of 4.3%| States Transparency Market Research, Inc.
December 15, 2023 04:30 ET | Transparency Market Research
Wilmington, Delaware, United States, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The actuators and valves market was worth US$ 415.3 million in 2022. A CAGR of 4.3% is...
BMS Attributes Sotyk
BMS Attributes Sotyktu Falling Short of Growth Expectations to Access, but Recent Spherix Global Insights’ Data Suggest Safety Concerns Are More of a Barrier to Increased Uptake
December 07, 2023 12:01 ET | Spherix Global Insights
Exton, PA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- While access took the forefront of BMS’ response to Sotyktu (deucravacitinib) not meeting growth expectations during the company’s Q3 earnings call,...
YSEOP_LOGO_FINAL-PURPLE-_-YELLOW (1).png
Yseop Announces Strategic Investment and Celebrates Milestone of 150 Clinical Trials Powered by Generative AI
December 07, 2023 09:00 ET | Yseop
NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Yseop, a world-leading Generative AI company for life sciences, today announces the closing of a strategic investment round, with new investor Novartis...
Celcuity+Logo.jpg
Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer Symposium
December 06, 2023 08:30 ET | Celcuity Inc.
MINNEAPOLIS, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today presented data from...
Transparency Market Research
Commercial Seaweed Market to Hit USD 31.1 billion by 2031, at a CAGR 7.0% | Says Transparency Market Research, Inc.
December 01, 2023 12:30 ET | Transparency Market Research
Wilmington, Delaware, United States, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global commercial seaweed market is estimated to flourish at a CAGR of 7.0% from 2022...
Celcuity+Logo.jpg
Celcuity to Present Preclinical Data for Gedatolisib at the 2023 San Antonio Breast Cancer Symposium
December 01, 2023 11:02 ET | Celcuity Inc.
MINNEAPOLIS, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that an...
ZoomRx TV Tracking
ZoomRx Announces Launch of ZoomRx TV Tracking: The First TV Media Measurement and Optimization Platform Designed for Life Sciences
November 29, 2023 12:33 ET | ZoomRx
CAMBRIDGE, Mass., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Global life sciences consulting firm ZoomRx is set to transform how life sciences brands monitor and evaluate TV ad campaigns with today’s launch...
MnM_logo_TM_JPG.JPG
Single Use Assemblies Market worth $5.2 billion | MarketsandMarkets.
November 29, 2023 08:00 ET | MarketsandMarkets Research Pvt. Ltd.
Chicago, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Single Use Assemblies Market in terms of revenue was estimated to be worth $2.5 billion in 2023 and is poised to reach $5.2 billion in 2028, growing at a...